ATE270295T1 - Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit - Google Patents
Benzoxazine zur verwendung in der behandlung parkinsonscher krankheitInfo
- Publication number
- ATE270295T1 ATE270295T1 AT01925065T AT01925065T ATE270295T1 AT E270295 T1 ATE270295 T1 AT E270295T1 AT 01925065 T AT01925065 T AT 01925065T AT 01925065 T AT01925065 T AT 01925065T AT E270295 T1 ATE270295 T1 AT E270295T1
- Authority
- AT
- Austria
- Prior art keywords
- parkinson
- disease
- benzoxazine
- treatment
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20278700P | 2000-05-09 | 2000-05-09 | |
| PCT/US2001/012528 WO2001085734A1 (en) | 2000-05-09 | 2001-04-17 | Benzoxazines for use in the treatment of parkinson's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE270295T1 true ATE270295T1 (de) | 2004-07-15 |
Family
ID=22751255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01925065T ATE270295T1 (de) | 2000-05-09 | 2001-04-17 | Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6812228B2 (de) |
| EP (1) | EP1282625B1 (de) |
| JP (1) | JP2003532733A (de) |
| AT (1) | ATE270295T1 (de) |
| AU (1) | AU2001251662A1 (de) |
| BR (1) | BR0110643A (de) |
| CA (1) | CA2407789A1 (de) |
| DE (1) | DE60104110T2 (de) |
| DK (1) | DK1282625T3 (de) |
| ES (1) | ES2223824T3 (de) |
| MX (1) | MXPA02010270A (de) |
| PT (1) | PT1282625E (de) |
| WO (1) | WO2001085734A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE112012002844T5 (de) | 2011-07-05 | 2014-04-24 | Electronic Scientific Industries, Inc. | Verfahren zur Laserbearbeitung mit einem thermisch stabilisierten akustooptischen Strahlablenker und thermisch stabilisiertes Hochgeschwindigkeits-Laserbearbeitungssystem |
| WO2014172372A1 (en) | 2013-04-15 | 2014-10-23 | Northwestern University | Treatment for dopaminergic disorders |
-
2001
- 2001-04-17 JP JP2001582334A patent/JP2003532733A/ja active Pending
- 2001-04-17 DK DK01925065T patent/DK1282625T3/da active
- 2001-04-17 US US10/275,825 patent/US6812228B2/en not_active Expired - Fee Related
- 2001-04-17 MX MXPA02010270A patent/MXPA02010270A/es not_active Application Discontinuation
- 2001-04-17 CA CA002407789A patent/CA2407789A1/en not_active Abandoned
- 2001-04-17 AU AU2001251662A patent/AU2001251662A1/en not_active Abandoned
- 2001-04-17 DE DE60104110T patent/DE60104110T2/de not_active Expired - Fee Related
- 2001-04-17 EP EP01925065A patent/EP1282625B1/de not_active Expired - Lifetime
- 2001-04-17 AT AT01925065T patent/ATE270295T1/de not_active IP Right Cessation
- 2001-04-17 WO PCT/US2001/012528 patent/WO2001085734A1/en active IP Right Grant
- 2001-04-17 ES ES01925065T patent/ES2223824T3/es not_active Expired - Lifetime
- 2001-04-17 PT PT01925065T patent/PT1282625E/pt unknown
- 2001-04-17 BR BR0110643-0A patent/BR0110643A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1282625A1 (de) | 2003-02-12 |
| US6812228B2 (en) | 2004-11-02 |
| DE60104110T2 (de) | 2005-08-25 |
| JP2003532733A (ja) | 2003-11-05 |
| DK1282625T3 (da) | 2004-11-15 |
| WO2001085734A1 (en) | 2001-11-15 |
| CA2407789A1 (en) | 2001-11-15 |
| US20030220335A1 (en) | 2003-11-27 |
| PT1282625E (pt) | 2004-10-29 |
| EP1282625B1 (de) | 2004-06-30 |
| AU2001251662A1 (en) | 2001-11-20 |
| BR0110643A (pt) | 2003-03-18 |
| DE60104110D1 (de) | 2004-08-05 |
| MXPA02010270A (es) | 2003-04-25 |
| ES2223824T3 (es) | 2005-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2668B1 (en) | Isoczazolins for controlling invertebrate insects | |
| DE60220422D1 (de) | Substituierte pyrazoloverbindungen zur behandlung von entzündungen | |
| SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| GB0318447D0 (en) | Therapeutic agents | |
| GB9524157D0 (en) | Therapeutic agents | |
| IL171977A0 (en) | Cyclic sulfonamides for inhibition of gamma-secretase | |
| SE0104332D0 (sv) | Therapeutic agents | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| BRPI0418181A (pt) | emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson | |
| TW200607808A (en) | Pyrido-pyrimidine derivatives, preparation thereof and application thereof | |
| UY25143A1 (es) | Procedimiento para la preparacion de inhibidores de proteasas. | |
| NZ528997A (en) | Sulfonamides | |
| ES2097496T3 (es) | Derivados acilaminoindol como agonistas de 5-ht1. | |
| DE69713273D1 (de) | Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms | |
| PE20050254A1 (es) | N-[3-(3-SUSTITUIDAS-PIRAZOLO [1,5-a]PIRIMIDIN-7-IL) FENIL]-SULFONAMIDAS Y COMPOSICIONES RELACIONADAS | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| DE60104110D1 (de) | Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit | |
| ATE397609T1 (de) | Corticotropinfreisetzungsfaktor antagonisten | |
| ATE273978T1 (de) | 7-aminopyrido(2,3-d)-pyrimidine derivate zur behandlung von bronchialasthma | |
| TW200612912A (en) | Benzyloxy derivatives as maob inhibitors | |
| ES2193047T3 (es) | (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas. | |
| DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| HUP0301561A2 (hu) | Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására | |
| ATE220665T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| WO2002088091A3 (en) | Inhibitors of human rhinovirus 2a cysteine protease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1282625 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |